XOMA Corp (XOMA)
25.60
-0.06
(-0.23%)
USD |
NASDAQ |
May 17, 12:32
XOMA Cash from Investing (TTM): -0.723M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -0.723M |
December 31, 2023 | -0.711M |
September 30, 2023 | -21.47M |
June 30, 2023 | -26.94M |
March 31, 2023 | -22.46M |
December 31, 2022 | -20.22M |
September 30, 2022 | -10.97M |
June 30, 2022 | -18.00M |
March 31, 2022 | -18.00M |
December 31, 2021 | -26.50M |
September 30, 2021 | -20.70M |
June 30, 2021 | -13.71M |
March 31, 2021 | -13.71M |
December 31, 2020 | -0.209M |
September 30, 2020 | -0.009M |
June 30, 2020 | -13.00M |
March 31, 2020 | -19.00M |
December 31, 2019 | -19.30M |
September 30, 2019 | -19.30M |
June 30, 2019 | -21.31M |
March 31, 2019 | -15.31M |
December 31, 2018 | -15.01M |
September 30, 2018 | -14.99M |
June 30, 2018 | -0.008M |
March 31, 2018 | 0.793M |
Date | Value |
---|---|
December 31, 2017 | 1.606M |
September 30, 2017 | 1.566M |
June 30, 2017 | 2.212M |
March 31, 2017 | 1.456M |
December 31, 2016 | 0.612M |
September 30, 2016 | 5.534M |
June 30, 2016 | 4.87M |
March 31, 2016 | 4.644M |
December 31, 2015 | 4.45M |
September 30, 2015 | 4.454M |
June 30, 2015 | 9.349M |
March 31, 2015 | 19.50M |
December 31, 2014 | 19.68M |
September 30, 2014 | -5.318M |
June 30, 2014 | -10.38M |
March 31, 2014 | -0.711M |
December 31, 2013 | 18.84M |
September 30, 2013 | 15.55M |
June 30, 2013 | 10.24M |
March 31, 2013 | -21.97M |
December 31, 2012 | -42.02M |
September 30, 2012 | -19.35M |
June 30, 2012 | -14.16M |
March 31, 2012 | -2.964M |
December 31, 2011 | -3.304M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-26.94M
Minimum
Jun 2023
-0.009M
Maximum
Sep 2020
-15.31M
Average
-18.50M
Median
Cash from Investing (TTM) Benchmarks
Kinnate Biopharma Inc (DELISTED) | 109.87M |
Societal CDMO Inc (DELISTED) | -8.237M |
Corcept Therapeutics Inc | -125.58M |
Sarepta Therapeutics Inc | 40.50M |
AnaptysBio Inc | 127.97M |